about
Established in 1968, Lupin is a global pharmaceutical company focused on developing and distributing a diverse range of healthcare products. Its portfolio includes generics, branded generics, complex generics, APIs, biosimilars, and specialty medicin...
Read More
2241.40
14.70
(0.66%)
236.7K
NSE+BSE Volume
NSE 19 Feb, 2026 12:06 PM (IST)
Signs Agreement
Lupin partners with Spektus to market DeslaFlex in Canada, with a market size of $1.3 bn in 2024
See details